There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Sana Biotechnology Inc (SANA) shows that investor sentiment remained same, with the stock’s consolidated last price to $3.08. The Sana Biotechnology Inc has recorded 45,873 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $3.08 and fluctuated between $3.2900 as its day high and $3.0650 as its day low. The current market capitalization of Sana Biotechnology Inc is $606.58M. A total of 1.11 million shares were traded on the day, compared to an average of 1.11M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, SANA has seen 0 BUY and 6 SELL insider trades, representing the acquisition of 0 and the disposition of 11,781,275 shares. Over the last 12 months, there were 5 BUYs and 14 SELLs from insiders. Insiders purchased 22,129 shares during that period but sold 12,526,517.
In the most recent transaction, Flagship Ventures Fund V Gener sold 200,000 shares of SANA for 6.24 per share on Jun 07. After the transaction, the 10% Owner now owns 1,380,277 company shares. In a previous transaction on Jun 06, Flagship Ventures Fund V Gener sold 203,758 shares at 6.31 per share. SANA shares that 10% Owner owns now total 1,403,037.
Among the insiders who sold shares, Flagship Ventures Fund V Gener disposed of 82,000 shares on May 26 at a per-share price of $6.23. This resulted in the 10% Owner holding 1,425,334 shares of SANA after the transaction. In another insider transaction, Flagship Ventures Fund V Gener sold 115,372 shares at $6.35 per share on May 25. Company shares held by the 10% Owner now total 1,434,664.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for SANA in the last 3 months, the mean price target is $9.20 with high estimates of $13.00 and low estimates of $6.00. In terms of 52-week highs and lows, SANA has a high of $8.01 and a low of $2.74.
As of this writing, SANA has an earnings estimate of -$0.45 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.5. The company reported an EPS of -$0.43 in the last quarter, which was 4.40% higher than expectations of -$0.45.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SANA’s latest balance sheet shows that the firm has $746.88M in Cash & Short Term Investments as of fiscal 2021. There were $110.94M in debt and $99.23M in liabilities at the time. Its Book Value Per Share was $1.80, while its Total Shareholder’s Equity was $728.50M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SANA is Buy with a score of 4.00.